RT @MDTolgaAksu: Endo-Epi ablation seems more effective not only in ARVD but also in ICMP. When we look at this graphic, we can also say th…
RT @MDTolgaAksu: Endo-Epi ablation seems more effective not only in ARVD but also in ICMP. When we look at this graphic, we can also say th…
RT @MDTolgaAksu: Endo-Epi ablation seems more effective not only in ARVD but also in ICMP. When we look at this graphic, we can also say th…
RT @JACCJournals: Is combined endo/epi approach better than endo only approach to #ablateVT in patients with structural heart disease? Read…
RT @JACCJournals: Is combined endo/epi approach better than endo only approach to #ablateVT in patients with structural heart disease? Read…
RT @MDTolgaAksu: Endo-Epi ablation seems more effective not only in ARVD but also in ICMP. When we look at this graphic, we can also say th…
RT @MDTolgaAksu: Endo-Epi ablation seems more effective not only in ARVD but also in ICMP. When we look at this graphic, we can also say th…
Endo-Epi ablation seems more effective not only in ARVD but also in ICMP. When we look at this graphic, we can also say that acute procedural success can not predict VT free survival in scar related VTs if you perform endo only ablation. Wonderful metaanal
RT @JACCJournals: Is combined endo/epi approach better than endo only approach to #ablateVT in patients with structural heart disease? Read…
RT @JACCJournals: Is combined endo/epi approach better than endo only approach to #ablateVT in patients with structural heart disease? Read…
RT @JACCJournals: Is combined endo/epi approach better than endo only approach to #ablateVT in patients with structural heart disease? Read…
RT @JACCJournals: Is combined endo/epi approach better than endo only approach to #ablateVT in patients with structural heart disease? Read…
RT @JACCJournals: Is combined endo/epi approach better than endo only approach to #ablateVT in patients with structural heart disease? Read…
RT @JACCJournals: Is combined endo/epi approach better than endo only approach to #ablateVT in patients with structural heart disease? Read…
RT @JACCJournals: Is combined endo/epi approach better than endo only approach to #ablateVT in patients with structural heart disease? Read…
RT @JACCJournals: Is combined endo/epi approach better than endo only approach to #ablateVT in patients with structural heart disease? Read…
RT @JACCJournals: Is combined endo/epi approach better than endo only approach to #ablateVT in patients with structural heart disease? Read…
RT @JACCJournals: Is combined endo/epi approach better than endo only approach to #ablateVT in patients with structural heart disease? Read…
@cavaco_diogo
RT @JACCJournals: Is combined endo/epi approach better than endo only approach to #ablateVT in patients with structural heart disease? Read…
RT @JACCJournals: Is combined endo/epi approach better than endo only approach to #ablateVT in patients with structural heart disease? Read…
RT @JACCJournals: Is combined endo/epi approach better than endo only approach to #ablateVT in patients with structural heart disease? Read…
RT @JACCJournals: Is combined endo/epi approach better than endo only approach to #ablateVT in patients with structural heart disease? Read…
Is combined endo/epi approach better than endo only approach to #ablateVT in patients with structural heart disease? Read about it in #JACCCEP: https://t.co/efMGSeEej7 https://t.co/ZwCUa5A3v2
RT @TKDsosyal: A meta-analysis including 975 pts suggested 35% ⬇️ risk in VT rec with endo-epi abl comp to endo alone. ICM and ARVD pts ben…
RT @ihtanboga: Study level meta-analysis of observational trials is completely unreliable without adjustment for patient characteristics re…
RT @ihtanboga: Study level meta-analysis of observational trials is completely unreliable without adjustment for patient characteristics re…
RT @TKDsosyal: A meta-analysis including 975 pts suggested 35% ⬇️ risk in VT rec with endo-epi abl comp to endo alone. ICM and ARVD pts ben…
RT @ihtanboga: Study level meta-analysis of observational trials is completely unreliable without adjustment for patient characteristics re…
Study level meta-analysis of observational trials is completely unreliable without adjustment for patient characteristics related to tx and/or outcome. What's solution: IPD meta-analysis!!! @canyucelkarabay @CinierGoksel https://t.co/a0EbVGuYrd
RT @TKDsosyal: A meta-analysis including 975 pts suggested 35% ⬇️ risk in VT rec with endo-epi abl comp to endo alone. ICM and ARVD pts ben…
RT @TKDsosyal: A meta-analysis including 975 pts suggested 35% ⬇️ risk in VT rec with endo-epi abl comp to endo alone. ICM and ARVD pts ben…
RT @TKDsosyal: A meta-analysis including 975 pts suggested 35% ⬇️ risk in VT rec with endo-epi abl comp to endo alone. ICM and ARVD pts ben…
A meta-analysis including 975 pts suggested 35% ⬇️ risk in VT rec with endo-epi abl comp to endo alone. ICM and ARVD pts benefited the most. Comp rates are ⬆️ with endo-epi approach. #JACCEP @JorgeERomeroMD @LuigiDiBiaseMD @andreanatalemd @DrRoderickTung
RT @SaurabhKumar_EP: #3DVT is a thing of beauty. Ablating it is even better. Is it better to go endo-epi in VT ablation? See our paper in p…
RT @SaurabhKumar_EP: #3DVT is a thing of beauty. Ablating it is even better. Is it better to go endo-epi in VT ablation? See our paper in p…
RT @SaurabhKumar_EP: #3DVT is a thing of beauty. Ablating it is even better. Is it better to go endo-epi in VT ablation? See our paper in p…
RT @SaurabhKumar_EP: #3DVT is a thing of beauty. Ablating it is even better. Is it better to go endo-epi in VT ablation? See our paper in p…
RT @DrRoderickTung: Compelling association with reduced mortality with epi-endo approach. #ablateVT #VTin3D https://t.co/F8mfVqOkmZ
RT @DrRoderickTung: Compelling association with reduced mortality with epi-endo approach. #ablateVT #VTin3D https://t.co/F8mfVqOkmZ
RT @DrRoderickTung: Compelling association with reduced mortality with epi-endo approach. #ablateVT #VTin3D https://t.co/F8mfVqOkmZ
RT @SaurabhKumar_EP: Thanks to all for a great collaborative effort. Our meta-analysis published in JACCEP online ahead of print. Bravo to…
Great collaboration. Nice prelude to our evolving stance to think #VTin3D. Much more to come, starting @VTSymposium!